SCHEMBL21035398

SCHEMBL21035398

COC(=O)[C@@H]1C[C@@H](Oc2ccc(Cl)cc2)CN1S(=O)(=O)c1ccc2cc(OC3CCCC3)ccc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 2/20 0.42
HTR7 P34969 2/20 0.42
HTR5A P47898 2/20 0.42
HTR2C P28335 2/20 0.42
HTR1D P28221 1/20 0.42
HTR1B P28222 1/20 0.42
HTR2A P28223 1/20 0.42
ADRA1A P35348 1/20 0.42
HTR2B P41595 1/20 0.42
HTR6 P50406 1/20 0.42
HTR4 Q13639 1/20 0.42
MMP1 P03956 1/20 0.42
MMP3 P08254 1/20 0.42
MMP9 P14780 1/20 0.42
ADAM17 P78536 1/20 0.42
ITGB1 P05556 2/20 0.42
ITGA4 P13612 2/20 0.42
CNR2 P34972 1/20 0.41
HCRTR1 O43613 4/20 0.40
HCRTR2 O43614 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21035317 1.00 HTR1A (0.42) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21034994 0.92 ITGB1 (0.47) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21034999 0.92 ITGB1 (0.47) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21034937 0.92 ITGB1 (0.47) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21035522 0.92 MMP1 (0.43) MMP1MMP3MMP9ADAM17ITGB1
SCHEMBL21035402 0.91 MMP1 (0.43) MMP1MMP3MMP9ADAM17HCRTR1
SCHEMBL21035318 0.91 MMP1 (0.43) MMP1MMP3MMP9ADAM17HCRTR1
SCHEMBL21035399 0.90 HTR1A (0.44) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21035314 0.90 HTR1A (0.44) HTR1AHTR7HTR5AHTR2CHTR1D
SCHEMBL21035678 0.89 ITGB1 (0.45) HTR1AHTR7HTR5AHTR2CHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019104011-A1 CERAMIDE GALACTOSYLTRANSFERASE INHIBITORS FOR THE TREATMENT OF DISEASE BIOMARIN PHARMACEUTICAL INC. (US) 2019-05-31 WO disclosed